Elutia Announces Sale of BioEnvelope Business to Boston Scientific for $88 Million
On Sept. 9, 2025, Elutia announced it has entered into a definitive agreement to sell its EluPro™ and…
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
On Sept. 8, 2025, Pfizer and BioNTech announced positive topline results from an ongoing Phase 3 clinical trial…
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
On Sept. 8, 2025, Femasys announced it has received approval from the New Zealand Medicines and Medical Devices…
eGenesis Announces IND Clearance for EGEN-2784 in Pig Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
On Sept. 8, 2025, eGenesis announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
Nearly half of people with diabetes don’t realize they have the disease
On Sept. 8, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
Study Led by Roswell Park Finds GLP-1 Receptor Agonists Improve Lung Cancer Outcomes
On Sept. 8, 2025, research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell…
Mpox outbreak in Africa is no longer a global health emergency
On Sept. 5, 2025, the World Health Organization announced that it no longer considers the mpox outbreak in…
Hope for diabetes: CRISPR-edited cells pump out insulin in a person — and evade immune detection
On Sept. 5, 2025, in a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into…
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine | Women's Health
Washington State Department of Health confirms COVID-19 vaccine position with Standing Order
On Sept. 5, 2025, The Washington State of Health (DOH) issued a Standing Order for the COVID-19 vaccine,…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
Hawaii to join West Coast Health Alliance with California, Oregon, and Washington
On Sept. 4, 2025, roughly 24 hours after the launch of the West Coast Health Alliance, Hawaii is…
Democratic Republic of the Congo Declares Ebola Virus Outbreak
On Sept. 4, 2025, Health authorities in the Democratic Republic of the Congo have declared an outbreak of…
Biological ‘moonshot’ accelerates efforts to genetically map life on earth
On Sept. 4, 2025, a global collaboration that includes experts at the Wellcome Sanger Institute announced mapping out…
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
On Sept. 4, 2025, Revvity announced the opening of its new In Vivo Imaging Center of Excellence in…
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
California, Oregon, and Washington to launch new West Coast Health Alliance to uphold scientific integrity in public health as Trump destroys CDC’s credibility
On Sept. 3, 2025, California Governor Gavin Newsom, Oregon Governor Tina Kotek, and Washington Governor Bob Ferguson announced…
Complete brain activity map revealed for the first time
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
Golden Goose Award Honors Federally Funded Breakthroughs in Cancer Treatments and Disease Diagnostics
On Sept. 3, 2025, The Golden Goose Award, which spotlights obscure, silly sounding or odd fundamental discovery research that…
C2N Diagnostics Expands St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
Avian flu found in North Dakota, South Dakota turkeys
On Sept. 3, 2025, Avian flu has hit turkey farms in North Dakota and South Dakota, the first…
Navy base in Italy reports case of West Nile virus
On Sept. 3, 2025, Navy hospital here is warning people to take precautions against West Nile virus after…
Amgen to Invest $600 Million in New State-of-the-Art Center for Science Innovation at U.S. Headquarters
On Sept. 2, 2025, Amgen announced plans to invest more than $600 million in a new, state-of-the-art center…
OMass Therapeutics announces Collaboration and License Agreement for IBD with Genentech Worth $420 Million
On Sept. 2, 2025, OMass Therapeutics announces an exclusive collaboration and license agreement with Genentech, a member of…
Biotechnology | NIH | Vaccine
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS®, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
On Sept. 2, 2025, Emergent BioSolutions announced it had received a $30 million contract modification from the Biomedical Advanced…
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
Biotechnology | Diagnostics | Disease | Neurology | Oncology
New genetic biomarker flags aggressive brain tumors
On Sept. 1, 2025, a multi-institutional study suggests that typically classifiication of meningiomas by appearances may be deceiving…
Duke Receives $69 Million NIH Grant to Translate Science into Better Health for All
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Influenza | Vaccine
MIT researchers develop AI tool to improve flu vaccine strain selection
On Aug. 28, 2025, scientists at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Abdul…
Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
CDC | COVID-19 | Infectious Disease | Influenza | Measles | NIH | Non-Profit Research | U.S. Congress | Vaccine | Women's Health
U.S. CDC chief exits after weeks in role, three top officials resign
On Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…